NEW YORK, Aug. 8, 2016 /PRNewswire/ -- Adoption of Companion Diagnostics for Increasing Efficacy of Therapies, Advantages of Multiplexing Over Traditional Assays, and Need for Effective Analytical Platforms in Research to Reduce Operational Costs, and Will Boost the Growth of the Multiplex Assays Market.
The multiplex assays market is projected to reach USD 3.76 billion by 2021 USD 2.66 billion in 2016, growing at a CAGR of 7.2% during the forecast period (2016–2021). In this report, the multiplex assays market is broadly segmented on the basis of product & service, type, technology, applications, end user, and region.
The multiplex assays market, based on the type, is categorized into nucleic acid-based assays and protein-based assays. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays. The protein based assays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to adoption of these assays in research purpose. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. Based on the technology, the multiplex assays market is categorized into multiplex polymerase chain reaction, multiplex arrays, and other technologies. The multiplex arrays segment is further divided into planar arrays and bead-based arrays. The multiplex arrays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to technological advancements emerging in this segment.
The U.S. is expected to account for the largest share of the multiplex assays market in 2016. Europe is the second-largest source for multiplex assays market; this regional market is driven by the availability of government funds for the research and development of multiplex assays. Asia-Pacific region is estimated to be the fastest growing region in the multiplex assays market during the forecast period due to the adoption of multiplex assays in this region.
New product launches is the dominant strategy adopted by key industry participants in the multiplex assays market to increase their market share and cater to unmet needs.
Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).
Reasons to buy this report:
This research report has focused on various levels of analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth market segments; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on multiplex assays products and services offered by the top players in the global multiplex assays market
- Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the multiplex assays market
- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for multiplex assays across regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global multiplex assays market
- Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the leading players in the global multiplex assays market
Read the full report: http://www.reportlinker.com/p04042222-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/multiplex-assays-market-by-product--type--technology--application--end-user---global-forecast-to-2021-300310713.html